Facebook
Twitter
LinkedIn
ForwardRegenBio Summit: Transforming Next-Gen Biotherapeutics 2024 - Live Only
Course Directors: Julie G. Allickson, Ph.D., Saranya P. Wyles, M.D., Ph.D., and Praneetha R. Elugunti, M.H.A., M.B.A.
December 9 - December 11, 2024 - Ponte Vedra Inn & Club - Ponte Vedra Beach, Florida
The RegenBio Summit is a gathering of thought leaders and experts at the forefront of regenerative medicine, biomanufacturing, and translational research. This dynamic event aims to accelerate the transformation of next-generation biotherapeutics. Our focus extends across diverse medical specialties, including orthopedics, oncology, cardiovascular medicine, neurosciences, and transplantation, among other medical and surgical specialties. This summit focuses on advancing pioneering regenerative biotherapies, setting the stage for a new era of medical and surgical possibilities.
| All Registrants | On or before October 14, 2024 | After October 14, 2024 |
|---|---|---|
| $775 | $875 |
*Special rates available for large group registration. Contact Melissa Tadeo (Tadeo.Melissa@mayo.edu) for more information.
Target Audience
This course is designed for researchers, physicians, resident fellows, and medical students interested in regenerative medicine.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Describe fundamental principles of regenerative medicine that are being used to provide regenerative solutions to patients.
- Review the process leading to clinical utilization of regenerative therapeutics.
- Summarize steps to bring discovery into the community through commercialization and outreach.
- Identify the challenges to effective delivery of regenerative therapeutics.
- Describe the current state of the field of organ manufacturing.
- Examine the most recent solutions adopted in the fields of regenerative science.
Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.
RegenBio Summit: Transforming Next-Gen Biotherapeutics 2024 |
Ponte Vedra Beach, Florida |
December 9, 2024 to December 11, 2024 |
Eastern Standard Time |
Day 1 | Monday, December 9, 2024 |
8:00 AM | Breakfast, Registration & Exhibits |
9:00 AM | Welcome Announcements |
9:15 AM | Keynote: Regulating Regenerative Therapies from IND to BLA
|
10:00 AM | Fireside Chat: Mistakes and Lessons Learned from FDA CBER Director's Desk. An Insight into Accelerated Approval Pathways
|
10:30 AM | Laryngeal Transplantation and Regeneration: Breaking the Silence |
11:00 AM | Break and Exhibits |
11:30 AM | Fireside Chat: Impact of Generative Artificial Intelligence on Cell and Gene Therapy |
12:00 PM | Lunch |
1:00 PM | Plenary Highlight: Can we Grow a Personalized Heart |
Tissue Engineering Plenary | |
1:30 PM | 3D Bioprinting Skin |
1:45 PM | Biologically Inspired Engineering Strategies to Treat Vascular Injury and Tissue Fibrosis Jae-Won Shin, Ph.D. |
2:00 PM | Fireside Chat: Exosomes, Are We There Yet? |
2:30 PM | Defining the Issues: FDA Approach to Centralized, Decentralized, and Point of Care Manufacturing |
3:00 PM | Break & Exhibits |
Regenerative Orthopedics: From Care to Cure | |
3:30 PM |
Hip RECLAIM: A Phase I Safety and Feasibility Trial of REcycled CartiLage Auto/Allo IMplantation for the Treatment and Repair of Focal Hip Cartilage Defects TBD
|
4:00 PM | Musculoskeletal/Orthopedic TBD
|
4:30 PM | Demonstration-From Discovery to Patient Senior Directors |
5:00 PM | Closing Comments |
5:30 PM | Welcome Reception |
Day 2 | Tuesday, December 10, 2024 |
8:30 AM | Breakfast with Experts |
FDA Unveiled: Navigating U.S. Regulations and Regulators | |
Harmonizing Excellence: A Global Odyssey to Meet GMP Requirements | |
| Process Development 101 |
| Advanced Biomanufacturing 101 |
| Quality Control 101 |
| Quality Assurance 101 |
9:30 AM | Fireside Chat: iPSC Readiness |
10:00 AM | Break & Exhibits |
10:30 AM | Keynote: Trial of Beremagene Geperpavec (B-VEC) for Dystrophic Epidermolysis Bullosa – First FDA-Approved Topical Gene Therapy
|
10:50 AM | Fireside Chat: Mistakes and Lessons Learned from Startups. An Insight into the Success Path of Krystal Biotech, Inc. |
11:15 AM | Business of Regenerative Medicine |
11:40 AM | Mayo MedTech Accelerator: The Future of Cell and Gene Therapy |
12:00 PM | Lunch/Exhibits |
1:00 PM | From the Desk of Mayo Clinic Center for Regenerative Biotherapeutics Medical Director |
Cell and Gene Therapy Plenary | |
1:30 PM | Role of Stem Cells in Vascular Injury |
1:45 PM | The Allure of Biomanufacturing Tregs for Inflammatory Bowel Disease |
2:00 PM |
CELLTOP: An Update from Autologous Adipose Derived Mesenchymal Stem Cells in the Treatment of Paralysis due to Traumatic Spinal Cord Injury
|
2:15 PM | Phase Ib/II Study of Autologous Dendritic Cell Therapy Delivered Intratumorally after Cryoablation in Combination with Pembrolizumab for Patients with Metastatic or Unresectable Melanoma |
2:30 PM | Fireside: Addressing Challenges in Translation of CGT |
3:00 PM | Break |
3:30 PM | Healthcare Innovation – Think Tank Fast Pitch |
|
To be announced |
| Writing DNA with RNA: Genome Engineering by Target Primed Reverse Transcription |
5:00 PM | Poster Session & Networking |
6:00 PM | Adjourn |
Day 3 | Wednesday, December 11, 2024 |
8:00 AM | Breakfast and Exhibits |
9:00 AM | Keynote: Exploring the Promise of CRISPR Therapeutics In Vivo and Cell Therapy Applications |
9:30 AM | Fireside Chat: Mistakes and Lessons Learned from Startups. An insight into the success path of Intellia Therapeutics, Inc. Maggie A. DiGuardo, M.D. |
10:00 AM | Roundtable: Opportunities and Challenges for Regenerative Healthcare in the Future Miguel Forte, Ph.D. |
10:30 AM | Panel: Ethics in Regenerative Biotherapeutics |
11:00 AM | Break & Exhibits |
11:30 AM | Plenary Highlight: Transforming Lives with Personalized Cancer Therapies Bruce L. Levine, Ph.D. |
12:00 PM | Lunch & Exhibits |
iPSC Therapy Plenary Moderator: Zachary Resch, PhD | |
1:00 PM | A Vision to Grow Stem Cells into Retinal Pigment Epithelium (RPE) for Eyesight |
1:15 PM | TBD |
1:30 PM | To be announced |
1:45 PM | Panel Discussion |
2:00 PM |
|
2:30 PM | Fireside Chat: Immunotherapy |
3:00 PM | Closing Remarks |
3:10 PM |
|
| Regenerative Rehabilitation Regenerative Nephrology Regenerative Pulmonology Regenerative Dermatology Regenerative Orthopedics Regenerative Vascular Surgery |
A limited block of guest rooms has been reserved at a special group rate of $329 (USD), per night, plus tax and a daily resort service charge of $20. To receive the special group rate, please identify yourself as a registrant of the Mayo Clinic RegenBio Summit and make your reservation before the room block is filled or by the expiration date of November 7, 2024. You may reserve your room by calling the hotel directly at 1-800-234-7842 or by clicking the Reservation Link.
Any applicable Florida State sales tax (currently 6.5%), St. John’s County resort tax (currently 5.0%), or other applicable taxes (if any) will be added to the total of all charges, including but not limited to the resort fee.
Reservation Link
All travel and lodging expenses are the sole responsibility of the individual registrant.
For information regarding exhibit opportunities, please reach out to Kristy Badder.
Price
Please update your profile to let us know if you have dietary restrictions or access requirements.
Commitment to Equity, Diversity and Inclusion
Mayo Clinic School of Continuous Professional Development (MCSCPD) strives to foster a learning environment in which individual differences are valued, allowing all to achieve their fullest potential.
Cancellation and Refund Policy
View Cancellation and Refund Policy
All requests must be submitted in writing using the Contact Us Form.
Any use of this site constitutes your agreement to the Terms and Conditions of Registration.